Sellas Life Sciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | 0 | ||
EBITDA | -7,621 | -9,645 | -8,177 |
EBIT | -15,242 | -19,290 | -16,354 |
Net Income | -7,470 | -9,566 | -8,135 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -9,682 | -10,761 | -10,325 |
Cash | 9,247 | 18,515 | 2,630 |
Basic Shares | 57,630 | 44,812 | 32,124 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,000 | $7,600 | $1 |
Gross Profit | 0 | 900 | 7,400 | 1 |
EBITDA | 529 | -31,950 | -19,663 | 26,524 |
EBIT | -37,340 | -32,407 | -20,936 | -16,757 |
Net Income | -37,340 | -40,652 | -20,699 | -16,757 |
Net Change In Cash | 0 | 1,000 | 7,600 | 1 |
Cost of Revenue | 28,025 | |||
Free Cash Flow | -36,910 | -28,309 | -26,021 | -10,417 |
Cash | 2,530 | 17,125 | 21,355 | 35,302 |
Basic Shares | 27,777 | 19,395 | 15,481 | 7,977 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.10 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.21 |
2023-12-31 | -$0.25 |
